Supporting Sponsor

Austrianni

A Few Words About the Conference

On behalf of United Scientific Group (a non-profit organization), we are delighted to welcome you all to the first inaugural International Virtual Conference on Mycobacterium tuberculosis Research and Drug Development (Myco.Tube-2023) to be held online on May 30-31, 2023.

This is a 2-day content-rich program covering state-of-the-art basic, clinical, and translational tuberculosis research. Attendees will learn about a broad range of cutting-edge technologies being applied to control tuberculosis and develop new therapies.

Tuberculosis is well-known infectious disease responsible for the most deaths worldwide and it has been recognized as one of the top infectious diseases. The big challenge is that increasing resistance to antituberculosis drugs and medications. Our speakers will provide their perspectives on the best strategies for controlling this important disease.

Our speakers will report on a broad range of technologies; more fundamentally, they will share their creative and novel perspectives on developing new therapies to control these widespread infections.

Myco.Tube-2023 will offer a unique opportunity for attendees to gain insights of the latest perspectives, updates, cutting-edge technological tools, and scientific advances in tuberculosis research and drug development.

We hope that you will enjoy this conference and benefit from networking with attendees and speakers.

WHY TO ATTEND?

Myco.Tube-2023 will bring together world-class clinicians, scientists, and investigators. This virtual conference provides an ideal, cost-effective format with as it offers:



Focused Presentations     

On the latest in tuberculosis research and drug development typically before publication.

Great Speakers     

Experience powerful education, learning, innovation by internationally recognized speakers.

Convenience     

Attend from your home or work, without risk of travel.

Cost-saving     

Engage without the expense and hassle of travel, hotel bookings, and spend your funds on Technology.

Speakers

Neeraj Dhar

Title: Antibiotic Persistence in Mycobacteria: Novel Insights from Single Cell Imaging

Neeraj Dhar

University of Saskatchewan
Canada

Martin Rottenberg

Title: Regulation of the Host Responses to Mycobacterium tuberculosis by Oxygen and Oxidants

Martin Rottenberg

Karolinska Institutet
Sweden

Sanjib Bhakta

Title: Anti-inflammatory Drugs to Tackle Antimicrobial Drug Resistance in Tuberculosis Treatment

Sanjib Bhakta

Birkbeck, University of London
United Kingdom

Rhea N. Coler

Title: The Feasibility of an RNA-based Vaccine for TB

Rhea N. Coler

University of Washington School of Medicine, WA, USA

Ruben HARTKOORN

Title: Discovery, Characterization and Development of Novel Natural Product-like Anti-tuberculosis Molecules

Ruben HARTKOORN

INSERM
France

Kristine B. Arnvig

Title: This is The End, Premature Termination of Transcription in Mycobacterium tuberculosis

Kristine B. Arnvig

University College London
United Kingdom

Prof. Seyed E. Hasnain

Title: Do the PE/PPE_PGRS Protein Families Present Exclusively in Mycobacteria Have Moonlighting Functions Including Conferring Drug Resistance

Seyed E. Hasnain

IIT, Delhi & Sharda University, Greater Noida, India

Hyungjin Eoh

Title: Chemical Biology at an Intersection of Metabolomics and Novel Drug Discovery in Mycobacterium tuberculosis

Hyungjin Eoh

Keck School of Medicine of USC
CA, USA

Dany Beste

Title: Diving Down A Rabbit Hole Trying to Understand TBs Metabolism

Dany Beste

University of Surrey
United Kingdom

Shuyi Ma

Title: Dissecting the Consequences of Ser/Thr Kinase Regulation in Mycobacterium tuberculosis

Shuyi Ma

Seattle Children’s Research Institute
WA, USA

Rafael Prados Rosales

Title: Vesiculogenesis as a Drug Target Against M. tuberculosis

Rafael Prados Rosales

Universidad Autonoma de Madrid
Spain

Inna Krieger

Title: Drug Development Targeting M. tuberculosis Central Carbon Metabolism

Inna Krieger

Texas A&M University
TX, USA

Sriram Chandrasekaran

Title: Drug Discovery and Repurposing Using Mechanistic AI

Sriram Chandrasekaran

University of Michigan
Ann Arbor, USA

Christopher Sundling

Title: Inflammatory Biomarkers as Tools to Identify TB Disease Progression

Christopher Sundling

Karolinska Institute
Sweden

Sharon L. Kendall

Title: The in vivo Essential List for Animal Adapted M. bovis in Cattle – A Useful Resource to Support Target Selection for Human Adapted M. tuberculosis?

Sharon L. Kendall

Royal Veterinary College
United Kingdom

Juraj Ivanyi

Title: Prospects for Reducing the Transmission of Tuberculosis by Active Case Finding

Juraj Ivanyi

Emeritus Professor, Kings College London
United Kingdom

Kimberlee A Musser

Title: Next Generation Sequencing Applications for the Detection of Drug Resistance in Clinical Cases of Tuberculosis in New York

Kimberlee A Musser

David Axelrod Institute
NY, USA

Dr. Robert Schnell

Title: Conventional and Novel β-lactams Targeting L,D-transpeptidase-2, the Rational Behind their Activity against M. tuberculosis

Robert Schnell

Karolinska Institutet
Sweden

Amit Singh

Title: S-adenosylmethionine Mediated Regulation of Transsulfuration Pathway modulates Redox Capacity of Mycobacterium tuberculosis

Amit Singh

Indian Institute of Science
Bangalore, India

Vivek Thacker

Title: The Mechanopathology of Biofilm-like Mycobacterium tuberculosis Cords

Vivek Thacker

Swiss Federal Institute of Technology in Lausanne (EPFL), Switzerland

Barbara Bosch

Title: When Essential Isn’t Good Enough: New Strategies for Target-based Drug Discovery in M. tuberculosis

Barbara Bosch

The Rockefeller University
NY, USA

Khushboo Borah Slater

Title: Mycobacterial Fluxomics: A Powerful Tool to Quantify Metabolism in TB and Identify Druggable Targets

Khushboo Borah Slater

University of Surrey
United Kingdom

Alexandre Gouzy

Title: Deciphering the Mode of Action of the Antibiotic Pyrazinamide at Acidic pH

Alexandre Gouzy

Weill Cornell Medicine
NY, USA

Lorissa Smulan

Title: Metabolic Reprogramming of Uninfected Macrophages by M. tuberculosis-infected Macrophages

Lorissa Smulan

UMass Chan Medical School
MA, USA

Maral Budak

Title: Optimizing Tuberculosis Treatment Efficacy to Identify Better Regimens

Maral Budak

University of Michigan Medical School
MI, USA

Petra de Haas

Title: Stool-based Xpert Testing Using The Simple One Step Stool Method: Evaluation of Robustness and Stool Transport Conditions Plus Country Experiences

Petra de Haas

KNCV Tuberculosis Foundation
The Netherlands

Saurabh Mishra

Title: Understanding the Transmission Biology of Mycobacterium tuberculosis

Saurabh Mishra

Weill Cornell Medicine
NY, USA

Divya Tiwaria

Title: Targeting Mycobacterium tuberculosis Biotin Protein Ligase: Combining Antimicrobial and Anti-virulence Therapy

Divya Tiwari

Queen Mary University of London
United Kingdom

Sangeeta Tiwari

Title: Targeting Achilles Heel of Mycobacterium tuberculosis to Accelerate TB Drug Discovery

Sangeeta Tiwari

University of Texas at El Paso
TX, USA

Contact Us

We are ready to lead you into the future of virtual conferences!
Use the below form to drops us an email. We will be in touch with lightning speed.